These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7541567)

  • 1. [Benign prostatic hyperplasia: prostatectomy and alternatives].
    Sulser T
    Ther Umsch; 1995 Jun; 52(6):383-92. PubMed ID: 7541567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transurethral laser therapy and urinary tract infections.
    Miller J; Ludwig M; Schroeder-Printzen I; Schiefer HG; Weidner W
    Ann Urol (Paris); 1996; 30(3):131-8. PubMed ID: 8766150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High temperature radiofrequency transurethral ablation of the prostate (TURAPY).
    Popov AI; Vasilevsky SI
    Wiad Lek; 1997; 50 Suppl 1 Pt 2():272-4. PubMed ID: 9383360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of new technical alternative procedures for therapy of symptomatic benign prostatic hyperplasia].
    Harzmann R; Weckermann D
    Urologe A; 1992 May; 31(3):150-8. PubMed ID: 1377432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical innovations in the treatment of benign prostatic hyperplasia: towards new standard treatments?].
    Cornu JN; Rouprêt M
    Prog Urol; 2007 Sep; 17(5 Suppl 1):1026-8. PubMed ID: 17969784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of the surgical procedure for management of benign prostatic hyperplasia.
    Mebust WK
    Prog Clin Biol Res; 1994; 386():369-84. PubMed ID: 7528405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive surgery in the management of benign prostatic hyperplasia.
    Berardinelli F; Hinh P; Wang R
    Minerva Urol Nefrol; 2009 Sep; 61(3):269-89. PubMed ID: 19773728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benign prostatic hyperplasia--choice of therapy in the elderly].
    Schultze-Seemann W
    Fortschr Med; 1993 Sep; 111(25):394-7. PubMed ID: 7691697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in the surgical management of benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):23-31. PubMed ID: 9586593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.
    Djavan B; Eckersberger E; Handl MJ; Brandner R; Sadri H; Lepor H
    Can J Urol; 2010 Aug; 17(4):5249-54. PubMed ID: 20735902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative treatment of prostatic urethral obstruction secondary to benign prostatic hypertrophy. Non-surgical balloon catheter prostatic dilatation.
    Castaneda F; Letourneau JG; Reddy P; Hulbert J; Hunter DW; Castaneda-Zuniga WR; Amplatz K
    Rofo; 1987 Oct; 147(4):426-9. PubMed ID: 2446357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy.
    Moody JA; Lingeman JE
    J Urol; 2001 Feb; 165(2):459-62. PubMed ID: 11176396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Minimal invasive therapy of benign prostatic hyperplasia].
    Madersbacher S; Marberger M
    Wien Med Wochenschr; 1996; 146(8):169-75. PubMed ID: 8767402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.